Rate and predictors of non‐response to first‐line antipsychotic treatment in first‐episode schizophrenia

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 3, 2015-05 ,pp. : 173-182

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia

By Ikeda Masashi   Yamanouchi Yoshio   Kinoshita Yoko   Kitajima Tsuyoshi   Yoshimura Reiji   Hashimoto Shuji   O’’Donovan Michael C   Nakamura Jun   Ozaki Norio   Iwata Nakao  

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1437-1443

Future Medicine

Access to resources Recommend Favorite

Managing the first episode of schizophrenia: the role of new therapies

By McCreadie R.G.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 200-200

Elsevier

Access to resources Recommend Favorite

Antipsychotic Drugs for First-Episode Schizophrenia: A Comparative Review

By Salimi Kayvon   Jarskog L. Fredrik   Lieberman Jeffrey A.  

CNS Drugs, Vol. 23, Iss. 10, 2009-10 ,pp. : 837-855

Adis International

Access to resources Recommend Favorite

Pharmacological Management of First-Episode Schizophrenia and Related Nonaffective Psychoses

By Bradford D.W.   Perkins D.O.   Lieberman J.A.  

Drugs, Vol. 63, Iss. 21, 2003-01 ,pp. : 2265-2283

Adis International

Access to resources Recommend Favorite